The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
Abstract
Nanoparticles in a biological fluid (plasma, or otherwise) associate with a range of biopolymers, especially proteins, organized into the “protein corona” that is associated with the nanoparticle and continuously exchanging with the proteins in the environment. Methodologies to determine the corona and to understand its dependence on nanomaterial properties are likely to become important in bionanoscience. Here, we study the long-lived (“hard”) protein corona formed from human plasma for a range of nanoparticles that differ in surface properties and size. Six different polystyrene nanoparticles were studied: three different surface chemistries (plain PS, carboxyl-modified, and amine-modified) and two sizes of each (50 and 100 nm), enabling us to perform systematic studies of the effect of surface properties and size on the detailed protein coronas. Proteins in the corona that are conserved and unique across the nanoparticle types were identified and classified according to the protein functional properties. Remarkably, both size and surface properties were found to play a very significant role in determining the nanoparticle coronas on the different particles of identical materials. We comment on the future need for scientific understanding, characterization, and possibly some additional emphasis on standards for the surfaces of nanoparticles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is clear evidence that each of these parameters also influences the nature of the biomolecules bound [139–141], and that different coronas lead to different biodistributions of NPs in vivo, as indicated above and demonstrated by Wang et al. [142]”
From Particle toxicology and health - where are we? (2019) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942 · cited 9×
“The 50-nm amine-modified particles have the highest number of detected apolipoproteins, 9 of the 10 identified being associated with HDL, suggesting that 50-nm amine-modified particles associate with HDL. Apolipoprotein B-100 (the major protein in VLDL and LDL particles, but not HDL) (16) is associated with all 50-nm…”
BackgroundInfluential
Research works printed but not linked: 18
- 10.1002/anie.200700465 · DOI
- 10.1073/pnas.0608582104 · DOI · Paper page
- 10.1016/S0939-6411(02)00081-4 · DOI
- 10.1002/jbm.a.10371 · DOI
- 10.1016/S0378-5173(99)00432-9 · DOI
- 10.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6 · DOI
- 10.1023/A:1012043131081 · DOI
- 10.1111/j.1365-2249.1990.tb05339.x · DOI
- 10.1074/mcp.R200007-MCP200 · DOI · Paper page
- 10.1002/pmic.200401233 · DOI
- 10.1016/j.bbrc.2005.12.098 · DOI
- 10.1002/pmic.200401010 · DOI
- 10.1002/pmic.200300938 · DOI
- 10.1002/pmic.200600339 · DOI
- 10.1002/pmic.200500191 · DOI
- 10.1172/JCI31608 · DOI
- 10.1021/ac950914h · DOI
- 10.1021/ac00104a020 · DOI
Cited by
Sorted by citations
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Plastic and Human Health: A Micro Issue?
Wright, S. L., & Kelly, F. J. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b00423 · Cited by 3,413
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Self-citationWalkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Time Evolution of the Nanoparticle Protein Corona
Casals, E., Pfaller, T., Duschl, A., Oostingh, G. J., & Puntes, V. (2010) · ACS Nano · doi:10.1021/nn901372t · Cited by 1,211
Nanoplastic Affects Growth of S. obliquus and Reproduction of D. magna
Besseling, E., Wang, B., Lürling, M., & Koelmans, A. A. (2014) · Environmental Science & Technology · doi:10.1021/es503001d · Cited by 1,138
Presence of microplastics and nanoplastics in food, with particular focus on seafood
(CONTAM), E. P. O. C. I. T. F. C. (2016) · EFSA Journal · doi:10.2903/j.efsa.2016.4501 · Cited by 958
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Abadeer, N. S., & Murphy, C. J. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b11232 · Cited by 919
Bertrand, N., Grenier, P., Mahmoudi, M., Lima, E. M., Appel, E. A., Dormont, F., Lim, J.-M., Karnik, R., Langer, R., & Farokhzad, O. C. (2017) · Nature Communications · doi:10.1038/s41467-017-00600-w · Cited by 708
Recent advances in toxicological research of nanoplastics in the environment: A review
Shen, M., Zhang, Y., Zhu, Y., Song, B., Zeng, G., Hu, D., Wen, X., & Ren, X. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.05.102 · Cited by 686
Altered Behavior, Physiology, and Metabolism in Fish Exposed to Polystyrene Nanoparticles
Mattsson, K., Ekvall, M. T., Hansson, L.-A., Linse, S., Malmendal, A., & Cedervall, T. (2015) · Environmental Science & Technology · doi:10.1021/es5053655 · Cited by 581
Self-citationNanotoxicology: An Interdisciplinary Challenge
Krug, H. F., & Wick, P. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201001037 · Cited by 556
Treuel, L., Brandholt, S., Maffre, P., Wiegele, S., Shang, L., & Nienhaus, G. U. (2014) · ACS Nano · doi:10.1021/nn405019v · Cited by 419
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps
Bergin, I. L., & Witzmann, F. A. (2013) · International Journal of Biomedical Nanoscience and Nanotechnology · doi:10.1504/ijbnn.2013.054515 · Cited by 412
Bacterial outer membrane vesicles as a platform for biomedical applications: An update
Li, M., Zhou, H., Yang, C., Wu, Y., Zhou, X., Liu, H., & Wang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.031 · Cited by 370
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
Brain-targeted drug delivery by manipulating protein corona functions
Zhang, Z., Guan, J., Jiang, Z., Yang, Y., Liu, J., Hua, W., Mao, Y., Li, C., Lu, W., Qian, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11593-z · Cited by 334
Nanoparticle protein corona: from structure and function to therapeutic targeting
Bashiri, G., Padilla, M. S., Swingle, K. L., Shepherd, S. J., Mitchell, M. J., & Wang, K. (2023) · Lab on a Chip · doi:10.1039/d2lc00799a · Cited by 296
Esch, M. B., Mahler, G. J., Stokol, T., & Shuler, M. L. (2014) · Lab Chip · doi:10.1039/c4lc00371c · Cited by 281
Micro- and nanoplastics: A new cardiovascular risk factor?
Zhu, X., Wang, C., Duan, X., Liang, B., Genbo Xu, E., & Huang, Z. (2023) · Environment International · doi:10.1016/j.envint.2022.107662 · Cited by 273
Particle toxicology and health - where are we?
Riediker, M., Zink, D., Kreyling, W., Oberdörster, G., Elder, A., Graham, U., Lynch, I., Duschl, A., Ichihara, G., Ichihara, S., et al. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0302-8 · Cited by 237
Self-citationXu, L., & Anchordoquy, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22243 · Cited by 209
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b00376 · Cited by 155
Bigdeli, A., Palchetti, S., Pozzi, D., Hormozi-Nezhad, M. R., Baldelli Bombelli, F., Caracciolo, G., & Mahmoudi, M. (2016) · ACS Nano · doi:10.1021/acsnano.6b00261 · Cited by 157
Current developments in antimicrobial surface coatings for biomedical applications
Swartjes, J. J. T. M., Sharma, P. K., Kooten, T. G., Mei, H. C., Mahmoudi, M., Busscher, H. J., & Rochford, E. T. J. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867321666140916121355 · Cited by 149
Nanoparticle Transport Across the Placental Barrier: Pushing the Field Forward!
Muoth, C., Aengenheister, L., Kucki, M., Wick, P., & Buerki-Thurnherr, T. (2016) · Nanomedicine · doi:10.2217/nnm-2015-0012 · Cited by 146
PEGylated nanomedicines: recent progress and remaining concerns
Vllasaliu, D., Fowler, R., & Stolnik, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866651 · Cited by 137
The potential of protein–nanomaterial interaction for advanced drug delivery
Peng, Q., & Mu, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.041 · Cited by 134
Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells
Caracciolo, G., Palchetti, S., Colapicchioni, V., Digiacomo, L., Pozzi, D., Capriotti, A. L., La Barbera, G., & Laganà, A. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b02158 · Cited by 131
Liu, S., Liu, J., Li, H., Mao, K., Wang, H., Meng, X., Wang, J., Wu, C., Chen, H., Wang, X., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121645 · Cited by 122
An Integrated Approach to the Study of the Interaction between Proteins and Nanoparticles
Turci, F., Ghibaudi, E., Colonna, M., Boscolo, B., Fenoglio, I., & Fubini, B. (2010) · Langmuir · doi:10.1021/la904758j · Cited by 118
Zhang, B., Yan, W., Zhu, Y., Yang, W., Le, W., Chen, B., Zhu, R., & Cheng, L. (2018) · Advanced Materials · doi:10.1002/adma.201705694 · Cited by 113
Ho, Y. T., Kamm, R. D., & Kah, J. C. Y. (2018) · Nanoscale · doi:10.1039/c8nr02393j · Cited by 102
Nanoplastic Toxicity: Insights and Challenges from Experimental Model Systems
Schröter, L., & Ventura, N. (2022) · Small · doi:10.1002/smll.202201680 · Cited by 99
Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., & Florán, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.009 · Cited by 102
Nagai, H., & Toyokuni, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02326.x · Cited by 98
Nanotechnology-Based Strategies to Overcome Current Barriers in Gene Delivery
Mirón-Barroso, S., Domènech, E. B., & Trigueros, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168537 · Cited by 91
Characteristics of nano-plastics in bottled drinking water
Huang, Y., Wong, K. K., Li, W., Zhao, H., Wang, T., Stanescu, S., Boult, S., van Dongen, B., Mativenga, P., & Li, L. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127404 · Cited by 84
Beyond the protein corona—Lipids matter for biological response of nanocarriers
Müller, J., Prozeller, D., Ghazaryan, A., Kokkinopoulou, M., Mailänder, V., Morsbach, S., & Landfester, K. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.02.036 · Cited by 79
Polystyrene nanoparticles activate ion transport in human airway epithelial cells
McCarthy, J., Gong, Nahirney, Duszyk, & Radomski (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s21145 · Cited by 71
Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery
Kim, J., Jozic, A., & Sahay, G. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00619-y · Cited by 61
How Can We Exploit The Protein Corona?
Hamad-Schifferli, K. (2013) · Nanomedicine · doi:10.2217/nnm.12.179 · Cited by 57
The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy
Mortensen, N. P., Durham, P., & Hickey, A. J. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.932029 · Cited by 52
Stewart, M., Mulenos, M. R., Steele, L. R., & Sayes, C. M. (2018) · Applied Sciences · doi:10.3390/app8122669 · Cited by 21
The role of the protein Corona in fiber structure-activity relationships
Kucki, M., Kaiser, J.-P., Clift, M., Rothen-Rutishauser, B., Petri-Fink, A., & Wick, P. (2014) · Fibers · doi:10.3390/fib2030187 · Cited by 7
High-density Lipoprotein Inspired Lipid Nanoparticles for Systemic RNA delivery to the Brain
Xu, Z., Shalin, K., Do, V., Yan, A., & Gao, J. (2026) · doi:10.64898/2026.05.29.728695
Metadata
- Authors
- Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-23
- Volume
- 105
- Issue
- 38
- Pages
- 14265-14270
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 2,823
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review